pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
cabiralizumab
cabiralizumab [INN]
Pigmented Villonodular Synovitis
Bristol-Myers Squibb Co
0 catalysts
pre_registration
cabozantinib
Hepatocellular Carcinoma
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
Lotus Pharmaceutical Co Ltd
0 catalysts
Phase 3
cadisegliatin
Type 1 Diabetes (Juvenile Diabetes)
vTv Therapeutics Inc.
← prev
page 162 of 231
next →
131
Pain89
Neurology1
$VTVT
0 catalysts
Phase 2
cafelkibart
cafelkibart [INN]
Solid Tumor
LaNova Medicines Ltd
0 catalysts
Phase 2
caffeine
Respiratory Depression (Hypoventilation)
Adenosine receptor
OYE Therapeutics Inc
0 catalysts
Phase 3
caficrestat
Cardiomyopathy
Aldo-keto reductase family 1 member B1
Biossil Inc
0 catalysts
Marketed
calaspargase pegol
Asparlas (calaspargase pegol)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Servier Pharmaceuticals LLC
0 catalysts
Marketed
calcifediol ER
Rayaldee (calcifediol)
Secondary Hyperparathyroidism
OPKO Pharmaceuticals LLC
0 catalysts
Marketed
calcitriol
Calcitriol Sun Pharma (calcitriol)
Renal Osteodystrophy
Sun Pharmaceutical Industries Ltd
0 catalysts
Marketed
calcium acetate
Calcium Acetate (calcium acetate)
Hyperphosphatemia
Nostrum Pharmaceuticals LLC
0 catalysts
Marketed
calfactant
Infasurf (calfactant)
Neonatal Respiratory Distress Syndrome
Allergan USA Inc
0 catalysts
Phase 1
calotatug ginistinag
calotatug ginistinag [INN]
Colorectal Cancer
$DAWNDay One Biopharmaceuticals, Inc.
0 catalysts
Phase 2
calpurbatug
calpurbatug [INN]
Prosthetic Joint infections
Trellis Bioscience Inc
0 catalysts
Phase 3
camlipixant
Chronic Cough
P2X purinoceptor 3
$GSKGSK plc
0 catalysts
Phase 2
camonsertib
Solid Tumor
XenoTherapeutics Inc
0 catalysts
Phase 2
camupepimut
Colorectal Cancer
$ELTXElicio Therapeutics, Inc.
0 catalysts
Preclinical
candesartan
Pancreatic Ductal Adenocarcinoma
Hebrew University of Jerusalem
0 catalysts
Marketed
candesartan cilexetil
Candesartan Cilexetil Par (candesartan cilexetil)
Congestive Heart Failure (Heart Failure)
Par Pharmaceutical Inc
0 catalysts
Phase 2
canerpaturev
Metastatic Melanoma
Takara Bio Inc
0 catalysts
Marketed
cangrelor
Kengreal (cangrelor)
Coronary Thrombosis
Chiesi USA Inc
0 catalysts
Marketed
cannabidiol
Epidiolex (cannabidiol)
Infantile Spasm (West Syndrome)
Cannabinoid receptor 1
$JAZZJazz Pharmaceuticals plc
0 catalysts
Preclinical
cannabidiol + naltrexone ER
cannabidiol + naltrexone
Opium (Opioid) Addiction
Aphios Corp
0 catalysts
Phase 2
cannabidivarin
Autism Spectrum Disorder (ASD)
$JAZZJazz Pharmaceuticals plc
0 catalysts
Marketed
cantharidin
Ycanth (cantharidin)
Warts
$VRCAVerrica Pharmaceuticals Inc.
0 catalysts
Phase 2
canvuparatide hydrochloride
Hypoparathyroidism
$MBXMBX Biosciences, Inc.
0 catalysts
Marketed
caplacizumab
Cablivi (caplacizumab-yhdp)
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)
Genzyme Corp
0 catalysts
Marketed
capmatinib hydrochloride
Tabrecta (capmatinib hydrochloride)
Non-Small Cell Lung Cancer
$NVSNOVARTIS AG
0 catalysts
Marketed
capsaicin
Qutenza (capsaicin)
Neuropathic Pain (Neuralgia)
Transient receptor potential cation channel subfamily V member 1
Grunenthal GmbH
0 catalysts
Marketed
captopril
Captopril (captopril)
Congestive Heart Failure (Heart Failure)
Innogenix Inc
0 catalysts
Marketed
carbinoxamine maleate
Carbinoxamine Maleate (carbinoxamine maleate)
Vasomotor Rhinitis
Mission Pharmacal Co
0 catalysts